Navigation Links
Artificial Ovaries Could Potentially Deliver Hormone Therapy
Date:3/29/2013

FRIDAY, March 29 (HealthDay News) -- It might be possible to create artificial ovaries in the laboratory to provide a more natural form of hormone replacement therapy (HRT) for women, researchers report.

As well as producing eggs, ovaries secrete hormones that are important for bone and heart health. Production of these hormones stops due to menopause, as well as surgical removal of the ovaries, chemotherapy and radiation treatments for certain types of cancer.

There are hormone replacement medications, but long-term use of the drugs is generally avoided due to the increased risk of heart disease and breast cancer, according to the authors of a new study published in the March issue of the journal Biomaterials.

In this study, a team from the Institute of Regenerative Medicine at Wake Forest Baptist Medical Center reported that ovaries created in the lab showed sustained release of the female sex hormones estrogen and progesterone.

"Our goal is to develop a tissue- or cell-based hormone therapy -- essentially an artificial ovary -- to deliver sex hormones in a more natural manner than drugs," study senior author Emmanuel Opara, a professor of regenerative medicine, said in a Wake Forest news release.

"A bioartificial ovary has the potential to secrete hormones in a natural way based on the body's needs, rather than the patient taking a specific dose of drugs each day," Opara explained.

The next research step -- evaluating the function of the ovarian structures in animals -- is already under way, Opara noted.

Commenting on the study, Dr. Tamer Yalcinkaya, an associate professor and section head of reproductive medicine at Wake Forest Baptist, said: "This research project is interesting because it offers hope to replace natural ovarian hormones in women with premature ovarian failure or in women going through menopause."

An artificial ovary "would bring certain advantages: It would eliminate pharmacokinetic variations of hormones when administered as drugs and would also allow body's feedback mechanisms to control the release of ovarian hormones," Yalcinkaya explained in the news release.

More information

The American Academy of Family Physicians has more about hormone replacement therapy.

-- Robert Preidt

SOURCE: Wake Forest Baptist Medical Center, news release, March 26, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Wearable artificial lung to be developed at Pitt through $3.4 million grant
2. Artificial Pancreas Worked Overnight on Kids With Type 1 Diabetes
3. Swine cells could power artificial liver
4. Hear This: 3-D Printing Creates Lifelike Artificial Ears
5. Artificial Organs (Medical Bionic Implants) Market is expected to grow at a CAGR of 7.1% & to reach $17.82 billion by 2017 - New Report by MarketsandMarkets
6. Artificial pancreas: The way of the future for treating type 1 diabetes
7. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
8. A leap forward in the quest to develop an artificial pancreas
9. Artificial butter flavoring ingredient linked to key Alzheimers disease process
10. Farmers tough on artificial limbs
11. Could Compound in Artificial Sweeteners Worsen Crohns Disease?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial Ovaries Could Potentially Deliver Hormone Therapy
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology: